Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin mai. 2021;71(3):209–49.

Article  Google Scholar 

Ahmad A. Breast cancer statistics: recent trends. Adv Exp Med Biol. 2019;1152:1–7.

Article  Google Scholar 

Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob Health août. 2020;8(8):e1027–37.

Article  Google Scholar 

Cowppli-Bony A, Colonna M, Ligier K, Jooste V, Defossez G, Monnereau A, et al. Descriptive epidemiology of cancer in metropolitan France: incidence, survival and prevalence. Bull Cancer août. 2019;106(7–8):617–34.

Article  Google Scholar 

https://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Synthese-Estimations-nationales-de-l-incidence-et-de-la-mortalite-par-cancer-en-France-metropolitaine-entre-1990-et-20182.

Dépistage du cancer du sein en France : identification des femmes à haut risque et modalités de dépistage [Internet]. Haute Autorité de Santé. [cité 9 juin 2021]. Disponible sur: https://www.has-sante.fr/jcms/c_1741170/fr/depistage-du-cancer-du-sein-en-france-identification-des-femmes-a-haut-risque-et-modalites-de-depistage

Glass AG, Lacey JV Jr, Carreon JD, Hoover RN. Breast cancer incidence, 1980–2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. JNCI J Natl Cancer Inst. 2007;99(15):1152–61.

Article  Google Scholar 

K Z, Ss A. Declining incidence of breast cancer after decreased use of hormone-replacement therapy: magnitude and time lags in different countries. J Epidemiol Commun Health. 2012;66(1). https://pubmed.ncbi.nlm.nih.gov/21875869/. (Internet)

Leclère B, Molinié F, Trétarre B, Stracci F, Daubisse-Marliac L, Colonna M, et al. Trends in incidence of breast cancer among women under 40 in seven European countries: a GRELL cooperative study. Cancer Epidemiol. 2013;37(5):544–9.

Article  Google Scholar 

Paluch-Shimon S, Cardoso F, Partridge AH, Abulkhair O, Azim HA, Bianchi-Micheli G, et al. ESO–ESMO 4th international consensus guidelines for breast cancer in young women (BCY4). Ann Oncol. 2020;31(6):674–96.

Article  Google Scholar 

Lanta Q, Arveux P, Asselain B. Epidemiology and socio-cultural specificities of young women with breast cancer. Bull Cancer. 2019;106(12S1):S4.

Article  Google Scholar 

Daly AA, Rolph R, Cutress RI, Copson ER. A review of modifiable risk factors in young women for the prevention of breast cancer. Breast Cancer. 2021;13:241–57.

Google Scholar 

Sancho-Garnier H, Colonna M. Breast cancer epidemiology. Presse Med. 2019;48(10):1076–84.

Article  Google Scholar 

Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008;26(20):3324–30.

Article  Google Scholar 

Fredholm H, Eaker S, Frisell J, Holmberg L, Fredriksson I, Lindman H. Breast cancer in young women: poor survival despite intensive treatment. PLoS ONE. 2009;4(11):e7695.

Article  Google Scholar 

Lambert PC, Royston P. Further development of flexible parametric models for survival analysis. Stata J. 2009;9(2):265–90.

Article  Google Scholar 

Colonna M, Delafosse P, Uhry Z, Poncet F, Arveux P, Molinie F, et al. Is breast cancer incidence increasing among young women? An analysis of the trend in France for the period 1983–2002. Breast Juin. 2008;17(3):289–92.

Article  Google Scholar 

Guo F, Kuo Y, et al. Trends in breast cancer mortality by stage at diagnosis among young women in the United States. Cancer. 2018;124(17):3500–9.

Article  Google Scholar 

SEER Cancer Statistics Review, 1975–2018 [Internet]. SEER. https://seer.cancer.gov/csr/1975_2018/index.html

Chen WY, Rosner B, Hankinson SE, Colditz GA, Willett WC. Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA. 2011;306(17):1884–90.

Article  Google Scholar 

Jung S, Wang M, Anderson K, Baglietto L, Bergkvist L, Bernstein L, et al. Alcohol consumption and breast cancer risk by estrogen receptor status: in a pooled analysis of 20 studies. Int J Epidemiol Juin. 2016;45(3):916–28.

Article  Google Scholar 

Macacu A, Autier P, Boniol M, Boyle P. Active and passive smoking and risk of breast cancer: a meta-analysis. Breast Cancer Res Treat. 2015;154(2):213–24.

Article  Google Scholar 

Dossus L, Boutron-Ruault MC, Kaaks R, Gram IT, Vilier A, Fervers B, et al. Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohort. Int J Cancer. 2014;134(8):1871–88.

Article  Google Scholar 

Andler R, Guignard R, Spilka S, Le Nézet O, Pasquereau A, Richard JB, et al. Smoking and vaping in France. Rev Mal Respir Juin. 2018;35(6):673–85.

Article  Google Scholar 

Premenopausal Breast Cancer Collaborative Group, Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, et al. Association of body mass index and age with subsequent breast cancer risk in premenopausal women. JAMA Oncol. 2018;4(11):e181771.

Article  Google Scholar 

Hardefeldt PJ, Penninkilampi R, Edirimanne S, Eslick GD. Physical activity and weight loss reduce the risk of breast cancer: a meta-analysis of 139 prospective and retrospective studies. Clin Breast Cancer août. 2018;18(4):e601–12.

Article  Google Scholar 

Tung N, Lin NU, Kidd J, Allen BA, Singh N, Wenstrup RJ, et al. Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer. J Clin Oncol. 2016;34(13):1460–8.

Article  Google Scholar 

Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266(5182):66–71.

Article  Google Scholar 

Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378(6559):789–92.

Article  Google Scholar 

Copson ER, Maishman TC, Tapper WJ, Cutress RI, Greville-Heygate S, Altman DG, et al. Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study. Lancet Oncol févr. 2018;19(2):169–80.

Article  Google Scholar 

BRCA1 and BRCA2 mutation testing in young women with breast cancer - PMC [Internet]. 2022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002892/

Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylkäs K, Roberts J, et al. Breast-cancer risk in families with mutations in PALB2. N Engl J Med. 2014;371(6):497–506.

Article  Google Scholar 

Moretta J, Berthet P, Bonadona V, Caron O, Cohen-Haguenauer O, Colas C, et al. The French genetic and cancer consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition. Bull Cancer. 2018;105(10):907–17.

Article  Google Scholar 

Partridge AH, Hughes ME, Warner ET, Ottesen RA, Wong YN, Edge SB, et al. Subtype-dependent relationship between young age at diagnosis and breast cancer survival. J Clin Oncol. 2016;34(27):3308–14.

Article  Google Scholar 

Nouvelles données sur la survie des personnes atteintes de cancer en France métropolitaine entre 1989 et 2018 : une amélioration de la survie pour la grande majorité des localisations cancéreuses étudiées [Internet]. [cité 18 janv 2022]. Disponible sur: https://www.santepubliquefrance.fr/presse/2021/nouvelles-donnees-sur-la-survie-des-personnes-atteintes-de-cancer-en-france-metropolitaine-entre-1989-et-2018-une-amelioration-de-la-survie-pour

Crocetti E, Roche L, Buzzoni C, di Costanzo F, Molinié F, Caldarella A, et al. Trends in net survival from breast cancer in six European Latin countries: results from the SUDCAN population-based study. Eur J Cancer Prev. 2017;26:S85-91.

Article  Google Scholar 

Collins LC, Marotti JD, Gelber S, Cole K, Ruddy K, Kereakoglow S, et al. Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat févr. 2012;131(3):1061–6.

Article  Google Scholar 

Gnerlich JL, Deshpande AD, Jeffe DB, Sweet A, White N, Margenthaler JA. Elevated breast cancer mortality in young women (<40 Years) compared with older women is attributed to poorer survival in early stage disease. J Am Coll Surg Mars. 2009;208(3):341–7.

Article  Google Scholar 

Johansson ALV, Trewin CB, Hjerkind KV, Ellingjord-Dale M, Johannesen TB, Ursin G. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort. Int J Cancer. 2019;144(6):1251–61.

Article  Google Scholar 

Fredholm H, Magnusson K, Lindström LS, Garmo H, Fält SE, Lindman H, et al. Long-term outcome in young women with breast cancer: a population-based study. Breast Cancer Res Treat. 2016;160(1):131–43.

Article  Google Scholar 

Liedtke C, Rody A, Gluz O, Baumann K, Beyer D, Kohls EB, et al. The prognostic impact of age in different molecular subtypes of breast cancer. Breast Cancer Res Treat Août. 2015;152(3):667–73.

Article  Google Scholar 

Kim HJ, Kim S, Freedman RA, Partridge AH. The impact of young age at diagnosis (age < 40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysis. Breast. 2021;61:77–83.

Article  Google Scholar 

Hershman DL, Kushi LH, Shao T, Buono D, Kershenbaum A, Tsai WY, et al. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol. 2010;28(27):4120–8.

Article  Google Scholar 

Swain SM, Jeong JH, Geyer CE, Costantino JP, Pajon ER, Fehrenbacher L, et al. Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med. 2010;362(22):2053–65.

Article  Google Scholar 

Bharat A, Aft RL, Gao F, Margenthaler JA. Patient and tumor characteristics associated with increased mortality in young women (< or =40 years) with breast cancer. J Surg Oncol. 2009;100(3):248–51.

Article  Google Scholar 

Partridge AH, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, et al. The effect of age on delay in diagnosis and stage of breast cancer. Oncologist. 2012;17(6):775–82.

Article  Google Scholar 

Smith IE, Fribbens C. Management of breast cancer in older and frail patients. Breast. 2015;24(Suppl 2):S159-162.

Article  Google Scholar 

Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, et al. Breast-cancer screening — viewpoint of the IARC working group. N Engl J Med. 2015;372(24):2353–8.

Article  Google Scholar 

Duffy SW, Tabár L, Yen AMF, Dean PB, Smith RA, Jonsson H, et al. Mammography screening reduces rates of advanced and fatal breast cancers: results in 549,091 women. Cancer. 2020;126(13):2971–9.

Article  Google Scholar 

Tabár L, Dean PB, Chen THH, Yen AMF, Chen SLS, Fann JCY, et al. The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening. Cancer. 2019;125(4):515–23.

Article  Google Scholar 

Hofvind S, Ponti A, Patnick J, Ascunce N, Njor S, Broeders M, et al. False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes. J Med Screen. 2012;19(Suppl 1):57–66.

Article  Google Scholar 

Hauge IHR, Pedersen K, Olerud HM, Hole EO, Hofvind S. The risk of radiation-induced breast cancers due to biennial mammographic screening in women aged 50–69 years is minimal. Acta Radiol déc. 2014;55(10):1174–9.

Article